Albuterol Sulfate Aerosol, Metered
Product Images NDC 71205-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 71205-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Albuterol Sulfate Hfa N021457 1)

FDA Label Image

Figure F (Albuterol Sulfate Hfa N021457 10)

FDA Label Image

Figure G (Albuterol Sulfate Hfa N021457 11)

FDA Label Image

Figure H (Albuterol Sulfate Hfa N021457 12)

FDA Label Image

Figure I (Albuterol Sulfate Hfa N021457 13)

FDA Label Image

Figure J (Albuterol Sulfate Hfa N021457 14)

FDA Label Image

Figure K (Albuterol Sulfate Hfa N021457 15)

FDA Label Image

71205-211-85 (Albuterol Sulfate Hfa N021457 17)

71205-211-85 (Albuterol Sulfate Hfa N021457 17)
This is a label of Albuterol Sulfate 90mcg inhaler lot #00000, which has been relabeled by ProficientRx LP in Thousand Oaks, CA. Each actuation delivers 108 mcg of albuterol sulfate, equivalent to 90 mcg of albuterol, from the mouthpiece. It is for RX Only and the package insert should be consulted. The medication should be stored between 15°C and 25°C (59°F and 77°F) and kept out of reach of children. The manufacturer is Teva Pharmaceuticals USA, Inc. and the product has a GTIN of 0037420821185.*
FDA Label Image

Day 1 Image (Albuterol Sulfate Hfa N021457 2)

Day 1 Image (Albuterol Sulfate Hfa N021457 2)
This appears to be a table with information about a study comparing the effects of different inhalation aerosols on the % change in FEV over time. There were three groups: one using Albuterol Sulfate HFA Inhalation Aerosol (N=58), one using Matched Placebo HFA Inhalation Aerosol (N=58), and one using a Marketed HFA-134a Albuterol Inhaler (N=56). The table shows the data for % change in FEV over time (measured in hours). Therefore this text is not sufficient to provide a useful description.*
FDA Label Image

Day 43 Image (Albuterol Sulfate Hfa N021457 3)

Day 43 Image (Albuterol Sulfate Hfa N021457 3)
This appears to be a table or graph showing the results of a study involving three different types of inhalation aerosols, including Albuterol Sulfate, a placebo, and a marketed brand. The table includes data on the number of participants in each group and displays the percentage change in FEV (Forced Expiratory Volume) over time in hours. Without further context or clarity, it is difficult to determine the specifics of the study or its findings.*
FDA Label Image

Teva Respiratory Logo (Albuterol Sulfate Hfa N021457 4)

FDA Label Image

Figure A (Albuterol Sulfate Hfa N021457 5)

Figure A (Albuterol Sulfate Hfa N021457 5)
This refers to a metal canister with a mouthpiece. No additional context or details are available.*
FDA Label Image

Figure B (Albuterol Sulfate Hfa N021457 6)

FDA Label Image

Figure C (Albuterol Sulfate Hfa N021457 7)

FDA Label Image

Figure D (Albuterol Sulfate Hfa N021457 8)

FDA Label Image

Figure E (Albuterol Sulfate Hfa N021457 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.